From: Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
Variable | TTP (OR 95% CI) | OS (OR 95% CI) |
---|---|---|
Grade | ||
Low | 1.00(reference) | 1.00(reference) |
High | 3.74(2.01–10.35) | 3.83(1.69–9.47) |
Ascites | ||
No | 1.00(reference) | 1.00(reference) |
Yes | 1.62(1.37–2.51) | 1.76(1.43–2.36) |
Optimal secondary CRS | ||
No | 1.00(reference) | 1.00(reference) |
Yes | 6.27(3.84–14.28) | 8.21(2.37–28.60) |
PFS | 1.02(1.00–1.14) | 1.10(1.04–1.36) |
Nadir CA-125 | 1.02(1.00–1.02) | 1.03(1.00–1.04) |